Skip to main content

New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer.

Publication ,  Journal Article
Salama, JK; Vokes, EE
Published in: J Clin Oncol
March 10, 2013

Recent advances in systemic cytotoxic and molecularly targeted therapies coupled with technologic strides in radiotherapy have the potential to improve outcomes for patients with non-small-cell lung cancer (NSCLC). Investigations are ongoing to identify optimal cytotoxin-based chemoradiotherapy platforms. The influence of specific histologic and molecular mutation status on the combination of targeted therapies and radiotherapy is also being actively studied. Although there are no convincing randomized phase III data to date supporting a survival advantage for combining molecularly targeted agents with radiation or chemoradiotherapy in the setting of locally advanced NSCLC, phase II and III studies targeted to elderly patients and those with poor performance status are elucidating preferred chemoradiotherapy strategies. Radiotherapy dose escalation did not improve chemoradiotherapy outcomes, although increasing radiation dose-intensity with modern techniques is being actively studied. As modern radiotherapy techniques have been shown to improve outcomes of some patients with limited metastatic disease, investigations are ongoing regarding how to optimally integrate them with standard chemotherapy platforms.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Clin Oncol

DOI

EISSN

1527-7755

Publication Date

March 10, 2013

Volume

31

Issue

8

Start / End Page

1029 / 1038

Location

United States

Related Subject Headings

  • Tomography, X-Ray Computed
  • Radiotherapy Dosage
  • Radiation-Sensitizing Agents
  • Proton Therapy
  • Positron-Emission Tomography
  • Patient Selection
  • Oncology & Carcinogenesis
  • Multimodal Imaging
  • Lung Neoplasms
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Salama, J. K., & Vokes, E. E. (2013). New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer. J Clin Oncol, 31(8), 1029–1038. https://doi.org/10.1200/JCO.2012.44.5064
Salama, Joseph K., and Everett E. Vokes. “New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer.J Clin Oncol 31, no. 8 (March 10, 2013): 1029–38. https://doi.org/10.1200/JCO.2012.44.5064.
Salama JK, Vokes EE. New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer. J Clin Oncol. 2013 Mar 10;31(8):1029–38.
Salama, Joseph K., and Everett E. Vokes. “New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer.J Clin Oncol, vol. 31, no. 8, Mar. 2013, pp. 1029–38. Pubmed, doi:10.1200/JCO.2012.44.5064.
Salama JK, Vokes EE. New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer. J Clin Oncol. 2013 Mar 10;31(8):1029–1038.

Published In

J Clin Oncol

DOI

EISSN

1527-7755

Publication Date

March 10, 2013

Volume

31

Issue

8

Start / End Page

1029 / 1038

Location

United States

Related Subject Headings

  • Tomography, X-Ray Computed
  • Radiotherapy Dosage
  • Radiation-Sensitizing Agents
  • Proton Therapy
  • Positron-Emission Tomography
  • Patient Selection
  • Oncology & Carcinogenesis
  • Multimodal Imaging
  • Lung Neoplasms
  • Humans